2. METHODS The AABB Board of Directors commissioned a committee of experts to draft clinical practice guidelines for the use of CCP. The primary focus was to evaluate whether …
The pandemic caused by the novel coronavirus, called SARS-CoV-2, affected more than one million people around the world. The COVID-19, the acronym derived from the …
M Murphy, L Estcourt, J Grant-Casey, S Dzik - Transfusion medicine …, 2020 - Elsevier
The collection and clinical use of COVID-19 convalescent plasma (CCP) as a therapy for COVID-19 infection is under development and early use in many centers worldwide. We …
AZ Al‐Riyami, R Schäfer, K van Den Berg… - Vox …, 2021 - Wiley Online Library
Background and objectives Use of convalescent plasma for coronavirus disease 2019 (COVID‐19) treatment has gained interest worldwide. However, there is lack of evidence on …
HC Sullivan, JD Roback - Transfusion medicine reviews, 2020 - Elsevier
As the world faces the current SARS-CoV-2 pandemic, extensive efforts have been applied to identify effective therapeutic agents. Convalescent plasma collected from recovered …
As the coronavirus disease (COVID-19) pandemic led to a global health crisis, there were limited treatment options and no prophylactic therapies for those exposed to severe acute …
2 MATERIALS AND METHODS This systematic review and meta-analysis were developed using the Preferred Reporting Instructions for Systematic Reviews and Meta-analysis …
H Cao, Y Shi - Transfusion, 2020 - ncbi.nlm.nih.gov
The recent coronavirus disease 2019 (COVID-19) epidemic is spreading all over the world. By March 23, over 300,000 patients had been confirmed and almost 15,000 died because of …
Background and objectives COVID‐19 convalescent plasma (CCP) has been used, predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest …